AstraZeneca wins approval of Imfinzi for additional bladder cancer type
AstraZeneca PLC · Now $185.67
+0.4% in 1d after detection
Post-detection moves
1h
—
1d
+0.4%
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS